Abstract Primidone given to a patient for epilepsy produced an unexpected reduction in benign familial tremor. Over the next eight years the drug was therefore tried in a prospective study of 20 other patients with benign familial tremor alone. Of these, six could not tolerate the drug because of vertigo and nausea but 12 obtained a good response, which in some cases was dramatic. Investigations in two patients suggested that the effect was mediated predominantly by derived phenylethylmalonamide, though primidone had some effect, since tremor recurred slightly on withdrawing the drug despite a constant or rising blood phenylethylmalonamide concentration.
Introduction
A patient with epilepsy and benign familial tremor was treated with primidone, and a remarkable effect was observed on the tremor. This chance finding led to the present study.
BENIGN FAMILIAL TREMOR
Benign familial tremor, or essential tremor, is common. It may cause only mild inconvenience, but in many patients it has a disabling effect on handwriting, drinking from a cup, doing up buttons, and other fine manipulations. Critchley2 reviewed early descriptions of the condition and quoted several brief accounts in continental reports from 1836; the first description in English was by Dann in 1887.
In a genetic and epidemiological study of 210 subjects, Lasson and Sj6gren' found evidence that the condition was inherited as an autosomal dominant, though sporadic cases often occur. The average age at onset was 50 years (range 10-70), and there appeared to be full penetrance of the gene by the age of 70. The phenomenon of anticipation from one generation to the next was not found, though this has been reported,' and there was no increased incidence of other neurological diseases or A 64-year-old right-handed electrician had had fine tremor of both hands for many years, which had become particularly troublesome over the past five years. He had worked in the electricity industry for 30 years, the last decade in a clerical job, and he had been a trade union official for 25 years. A few months before he was first seen (1973) he had lost his clerical job because of deterioration in his handwriting and he had been downgraded to a labouring job. Shortly afterwards he lost his union post for the same reason. He sought medical advice because of a request from his bank to give his wife power of attorney as they were unable to read his signature (fig l(a) ). (fig 1(b) ).
In 
Methods, results, and comment
Clinical observation showed a marked improvement in essential tremor during treatment with primidone, but it was not known whether this was due to the drug itself or to one of its principal metabolites, phenobarbitone and phenylethylmalonamide. Phenobarbitone was unlikely to be the cause because it and other barbiturates had been used for years with little or no benefit. The patients in cases 1 and 2 agreed to take part in a study to determine this point. Phenobarbitone 90 mg daily was substituted for primidone to maintain the blood phenobarbitone concentration, and within 24 hours both patients showed a deterioration in tremor; by four days they had great difficulty writing and could not drink from a full cup. Phenobarbitone was stopped and primidone restarted and within a few days tremor improved (fig 2) . The gradual deterioration of tremor over four days after stopping primidone suggested that the effect was due to phenylethylmalonamide (reported half life 30 hours) rather than primidone (half life 12 hours). One patient (case 2) was taking propranolol at the time of the study, and a similar procedure was adopted to compare the effect of primidone and propranolol. This showed a slight deterioration when propranolol was stopped and primidone continued and a marked deterioration when primidone was stopped but propranolol continued (fig 3) . It was then necessary to determine whether the effect was due to primidone or phenylethylmalonamide. Serial measurement of blood concentrations after a single encapsulated dose of phenylethylmalonamide 100 mg in a normal volunteer (MDO'B) showed a half life of 28 hours (1-0 mg/l at two hours; 0 9 mg/l at four, six, and eight hours; 0-8 mg/l at 11 hours; and 0-5 mg/l at 28 hours); 20% of the dose was excreted in urine over the first 10 hours. Phenylethylmalonamide 200 mg daily was substituted for primidone in both patients, and neither noticed any change in tremor in the first 24 figs 4 and 5) . At 48 hours one patient (case 2) showed no change but in the other the tremor was slightly worse. We assumed that this patient was not receiving enough phenylethylmalonamide and increased the dose to 400 mg daily. After 72 hours the tremor had improved in case 1 and was only slightly worse in case 2. Phenylethylmalonamide was then stopped and tremor deteriorated. Four days later both patients were incapacitated. Phenylethylmalonamide was restarted at 300 mg daily in case 2 and 400 mg daily in case 1, with rapid improvement. Phenobarbitone showed a plasma half life of 103 and 130 hours, primidone 16 hours, and phenylethylmalonamide 53 hours (nitrogen-selective gas chromatography5). 
Conclusion
Primidone is highly effective in benign familial tremor, and this effect appears to be mostly due to derived phenylethylmalonamide. Primidone itself appears to have some effect, however, since in both patients tremor deteriorated a little after stopping primidone despite a constant phenylethylmalonamide concentration in one and a rising phenylethylmalonamide concentration in the other. Primidone was more effective than propranolol and in some patients nearly as effective as alcohol. Adding propranolol resulted in some further improvement.
More patients (about 30%) with benign familial tremor were intolerant of primidone in small doses than is our clinical experience in patients with epilepsy.
(Accepted 31 October 1980) Effect of discotheque environment on epileptic children T P BERNEY, J W OSSELTON, I KOLVIN, M J DAY Abstract A free-field study of 22 epileptic children, selected on the basis of past electroencephalographic abnormality, identified a group who exhibited a significant increase in epileptiform discharge rate on electroencephalography in a discotheque environment (p <0 05). Laboratory investigations showed that these children were activated by a wide range of stimuli, including intermittent photic stimulation and exercise. The response to exercise was a good predictor of a child's electroencephalographic response in a discotheque.
The findings suggest that most epileptic children are not particularly vulnerable in a discotheque environment.
Introduction
The current popularity of discotheques has heightened the anxiety that loud music and flashing lights might be harmful, particularly to children with epilepsy. Consequently, some avoid discotheques, either on medical advice or because of their own or their parents' fears. This could be a social handicap.
The aims of this study were, firstly, to examine the neurophysiological effects of a simulated discotheque environment on a group of epileptic children by monitoring their electroencephalograms; and, secondly, to see whether those at risk could be identified by the use of electroencephalographic activation techniques in conventional laboratory surroundings.
Patients and methods
Twenty-two children aged 10-16 years met the criteria for admission to this study: normal intelligence and a history of epilepsy with sufficient epileptiform discharges in the electroencephalogram for changes to be measurable over short periods of time. Nearly all had suffered from generalised tonic-clonic seizures; 10 had a clinical history of photosensitivity. Fourteen avoided discotheques, nine because they had experienced discomfort when attending them.
Each recording session was in two parts: an initial electroencephalographic examination of about one hour's duration, including hyperventilation, exercise, and photic stimulation; followed by a period of about three-quarters of an hour in a simulated discotheque with other children. The electroencephalogram was recorded by radiotelemetry
